USFDA20 Feb 2025, 07:58 pm
Concord Biotech's Manufacturing Unit-1 Successfully Completes Inspection by Ministry of Food and Drug Safety
AI Summary
Concord Biotech Ltd has successfully completed an inspection conducted by the Ministry of Food and Drug Safety (MFDS) at its Manufacturing Unit-1 situated at Dholka. The inspection took place from Tuesday, 18th February, 2025 to Thursday 20th February, 2025. This achievement highlights the company's commitment to maintaining world-class quality systems and standards, and delivering high-quality products to its customers.
Key Highlights
- Concord Biotech's Manufacturing Unit-1 successfully completes inspection by Ministry of Food and Drug Safety (MFDS)
- Inspection conducted at the API facility located at Dholka, Gujarat
- Inspection took place from 18th to 20th February, 2025
- This achievement underscores the company's commitment to maintaining world-class quality systems and standards
- Concord Biotech remains dedicated to delivering the highest quality products to its customers